Ahmed NM, Eddama MMR, Beatson K, Gurung R, Patel J, Iskandar G, Abdel-Salam A, Al-Omar A, Cohen R, Abdel-Aziz T, Clapp L (2024) Circulating large extracellular vesicles as diagnostic biomarkers of indeterminate thyroid nodules: multi-platform omics analysis. BJS Open 9(1):zrae139. https://doi.org/10.1093/bjsopen/zrae139

Article  PubMed  PubMed Central  Google Scholar 

Buj R, Mallona I, Diez-Villanueva A, Zafon C, Mate JL, Roca M, Puig-Domingo M, Reverter JL, Mauricio D, Peinado MA, Jorda M (2018) Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications. Thyroid 28(5):601–612. https://doi.org/10.1089/thy.2017.0501

Article  CAS  PubMed  Google Scholar 

Cheng SP, Chen MJ, Chien MN, Lin CH, Lee JJ, Liu CL (2017) Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma. Clin Exp Med 17(4):555–564. https://doi.org/10.1007/s10238-016-0445-y

Article  CAS  PubMed  Google Scholar 

Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS, Liu CL (2020) Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. J Pathol 252(2):114–124. https://doi.org/10.1002/path.5503

Article  CAS  PubMed  Google Scholar 

Chi SY, Hsu YC, Cheng SP (2025a) Effect of genetic ancestry on phenotypes and genotypes in papillary thyroid cancer. OMICS 29(4):117–124. https://doi.org/10.1089/omi.2024.0189

Article  CAS  PubMed  Google Scholar 

Chi SY, Hsu YC, Tsai CH, Huang SY, Chang SC, Cheng SP (2025b) Identifying CSNK1E as a therapeutic target in thyroid cancer among the core circadian clock genes. Histochem Cell Biol 163(1):30. https://doi.org/10.1007/s00418-025-02357-6

Article  CAS  PubMed  Google Scholar 

Daneva GN, Tsiakanikas P, Adamopoulos PG, Scorilas A (2024) Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer. Expert Opin Ther Targets 28(10):875–894. https://doi.org/10.1080/14728222.2024.2415014

Article  CAS  PubMed  Google Scholar 

Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 70(7):2624–2633. https://doi.org/10.1158/0008-5472.CAN-09-3415

Article  CAS  PubMed  Google Scholar 

Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Potschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Huttelmaier S (2021) IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol 34(1):32–41. https://doi.org/10.1038/s41379-020-0630-0

Article  CAS  PubMed  Google Scholar 

Haddada M, Draoui H, Deschamps L, Walker F, Delaunay T, Brattsand M, Magdolen V, Darmoul D (2018) Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype. Biol Chem 399(9):1099–1105. https://doi.org/10.1515/hsz-2017-0339

Article  CAS  PubMed  Google Scholar 

Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18(9):533–548. https://doi.org/10.1038/s41568-018-0038-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

Hsu YC, Kuo CY, Chien MN, Jhuang JY, Huang SY, Chang SC, Cheng SP (2025) Overexpression of NR1D1 portends disease recurrence in thyroid cancer. J Clin Endocrinol Metab 110(4):991–1002. https://doi.org/10.1210/clinem/dgae687

Article  CAS  PubMed  Google Scholar 

Keskiner OO, Ozturk Y, Ozer H, Baloglu I, Uysal S, Toker A, Keskin S, Turkmen K (2024) Evaluation of the association of serum sclerostin and carotid intima media thickness with chronic kidney failure and kidney transplantation. Int J Gerontol 18(3):144–149. https://doi.org/10.6890/IJGE.202407_18(3).0002

Article  Google Scholar 

Kim HS, Kim DH, Kim JY, Jeoung NH, Lee IK, Bong JG, Jung ED (2010) Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med 25(4):399–407. https://doi.org/10.3904/kjim.2010.25.4.399

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kind S, Castillo CP, Schlichter R, Gorbokon N, Lennartz M, Hornsteiner LS, Dwertmann Rico S, Reiswich V, Viehweger F, Kluth M, Hube-Magg C, Bernreuther C, Buscheck F, Clauditz TS, Fraune C, Hinsch A, Krech T, Lebok P, Steurer S, Burandt E, Minner S, Marx AH, Simon R, Wilczak W, Sauter G, Menz A, Jacobsen F (2024) KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors. BMC Cancer 24(1):794. https://doi.org/10.1186/s12885-024-12552-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kryza T, Silva ML, Loessner D, Heuze-Vourc’h N, Clements JA (2016) The kallikrein-related peptidase family: dysregulation and functions during cancer progression. Biochimie 122:283–299. https://doi.org/10.1016/j.biochi.2015.09.002

Article  CAS  PubMed  Google Scholar 

Kuo CY, Chang YC, Chien MN, Jhuang JY, Hsu YC, Huang SY, Cheng SP (2021) SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway. Endocr Relat Cancer 29(2):47–58. https://doi.org/10.1530/ERC-21-0256

Article  PubMed  Google Scholar 

Kuo CY, Hsu YC, Chen MJ, Lin CH, Li YS, Cheng SP (2025) Glucose transporter 1 inhibitors induce autophagy and synergize with lenvatinib in thyroid cancer cells. Head Neck 47(2):615–624. https://doi.org/10.1002/hed.27953

Article  PubMed  Google Scholar 

Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE (2019) Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies. Clin Cancer Res 25(10):3141–3151. https://doi.org/10.1158/1078-0432.CCR-18-2953

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JJ, Hsu YC, Kuo CY, Huang SY, Chang SC, Cheng SP (2025) A TIMELESS link to dedifferentiation in thyroid cancer. J Endocrinol 267(1):e250136. https://doi.org/10.1530/JOE-25-0136

Article  CAS  PubMed  Google Scholar 

Li M, Li ZW, Song JY, Bin Y, Ni T, Xue G, Lin X, Wu JF (2025) KLK7 involvement in thyroid papillary carcinoma cell migration and invasion by EMT via MAPK/ERK pathways. J Cancer 16(5):1709–1725. https://doi.org/10.7150/jca.101555

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu CL, Hsu YC, Kuo CY, Jhuang JY, Li YS, Cheng SP (2022) CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the integrin/FAK/AKT pathway. Endocrinology 163(12):bqac171. https://doi.org/10.1210/endocr/bqac171

Article  CAS  PubMed  Google Scholar 

Nauroy P, Nystrom A (2019) Kallikreins: essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease. Matrix Biol plus 6–7:100019. https://doi.org/10.1016/j.mbplus.2019.100019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni T, Zhao RH, Wu JF, Li CY, Xue G, Lin X (2024) KLK7, KLK10, and KLK11 in papillary thyroid cancer: bioinformatic analysis and experimental validation. Biochem Genet 62(6):4446–4471. https://doi.org/10.1007/s10528-024-10679-8

Article  CAS  PubMed  Google Scholar 

Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A, Moscatello A, Schantz S, Tiwari RK, Geliebter J (2019) Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomark 24(1):71–83. https://doi.org/10.3233/CBM-181758

Article  CAS  PubMed